ECOVYST INC (ECVT) Fundamental Analysis & Valuation

NYSE:ECVTUS27923Q1094

Current stock price

11.65 USD
-0.11 (-0.94%)
At close:
11.65 USD
0 (0%)
After Hours:

This ECVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ECVT Profitability Analysis

1.1 Basic Checks

  • In the past year ECVT was profitable.
  • ECVT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ECVT reported negative net income in multiple years.
  • ECVT had a positive operating cash flow in 4 of the past 5 years.
ECVT Yearly Net Income VS EBIT VS OCF VS FCFECVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

  • The Return On Assets of ECVT (-6.16%) is worse than 73.49% of its industry peers.
  • ECVT's Return On Equity of -17.58% is on the low side compared to the rest of the industry. ECVT is outperformed by 69.88% of its industry peers.
  • ECVT has a Return On Invested Capital (4.78%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ECVT is in line with the industry average of 6.41%.
Industry RankSector Rank
ROA -6.16%
ROE -17.58%
ROIC 4.78%
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
ECVT Yearly ROA, ROE, ROICECVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • ECVT has a better Operating Margin (11.78%) than 63.86% of its industry peers.
  • In the last couple of years the Operating Margin of ECVT has grown nicely.
  • ECVT has a Gross Margin of 24.21%. This is comparable to the rest of the industry: ECVT outperforms 43.37% of its industry peers.
  • In the last couple of years the Gross Margin of ECVT has declined.
Industry RankSector Rank
OM 11.78%
PM (TTM) N/A
GM 24.21%
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
ECVT Yearly Profit, Operating, Gross MarginsECVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

4

2. ECVT Health Analysis

2.1 Basic Checks

  • ECVT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ECVT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ECVT Yearly Shares OutstandingECVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECVT Yearly Total Debt VS Total AssetsECVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ECVT has an Altman-Z score of 1.20. This is a bad value and indicates that ECVT is not financially healthy and even has some risk of bankruptcy.
  • ECVT has a worse Altman-Z score (1.20) than 72.29% of its industry peers.
  • ECVT has a debt to FCF ratio of 11.56. This is a negative value and a sign of low solvency as ECVT would need 11.56 years to pay back of all of its debts.
  • ECVT's Debt to FCF ratio of 11.56 is in line compared to the rest of the industry. ECVT outperforms 59.04% of its industry peers.
  • ECVT has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
  • ECVT has a worse Debt to Equity ratio (1.39) than 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 11.56
Altman-Z 1.2
ROIC/WACC0.57
WACC8.42%
ECVT Yearly LT Debt VS Equity VS FCFECVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ECVT has a Current Ratio of 2.25. This indicates that ECVT is financially healthy and has no problem in meeting its short term obligations.
  • ECVT has a better Current ratio (2.25) than 66.27% of its industry peers.
  • ECVT has a Quick Ratio of 2.07. This indicates that ECVT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.07, ECVT is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.07
ECVT Yearly Current Assets VS Current LiabilitesECVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. ECVT Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.45% over the past year.
  • The earnings per share for ECVT have been decreasing by -12.80% on average. This is quite bad
EPS 1Y (TTM)3.45%
EPS 3Y-10.96%
EPS 5Y-12.8%
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.56%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.08% on average over the next years. This is quite good.
  • Based on estimates for the next years, ECVT will show a quite strong growth in Revenue. The Revenue will grow by 10.43% on average per year.
EPS Next Y3.67%
EPS Next 2Y19.3%
EPS Next 3Y16.08%
EPS Next 5YN/A
Revenue Next Year10.73%
Revenue Next 2Y9.36%
Revenue Next 3Y10.43%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ECVT Yearly Revenue VS EstimatesECVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ECVT Yearly EPS VS EstimatesECVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

3

4. ECVT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.42, which indicates a rather expensive current valuation of ECVT.
  • ECVT's Price/Earnings ratio is in line with the industry average.
  • ECVT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
  • A Price/Forward Earnings ratio of 18.73 indicates a rather expensive valuation of ECVT.
  • ECVT's Price/Forward Earnings ratio is in line with the industry average.
  • ECVT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 19.42
Fwd PE 18.73
ECVT Price Earnings VS Forward Price EarningsECVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ECVT's Enterprise Value to EBITDA is on the same level as the industry average.
  • ECVT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ECVT is cheaper than 75.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.42
EV/EBITDA 12.29
ECVT Per share dataECVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ECVT's earnings are expected to grow with 16.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.29
PEG (5Y)N/A
EPS Next 2Y19.3%
EPS Next 3Y16.08%

0

5. ECVT Dividend Analysis

5.1 Amount

  • No dividends for ECVT!.
Industry RankSector Rank
Dividend Yield 0%

ECVT Fundamentals: All Metrics, Ratios and Statistics

ECOVYST INC

NYSE:ECVT (3/20/2026, 8:04:00 PM)

After market: 11.65 0 (0%)

11.65

-0.11 (-0.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)04-29
Inst Owners108.75%
Inst Owner Change-2.36%
Ins Owners1.69%
Ins Owner Change1.57%
Market Cap1.29B
Revenue(TTM)N/A
Net Income(TTM)-106.87M
Analysts81.67
Price Target12.24 (5.06%)
Short Float %3.91%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.02%
Min EPS beat(2)19.79%
Max EPS beat(2)20.26%
EPS beat(4)4
Avg EPS beat(4)45.97%
Min EPS beat(4)15.13%
Max EPS beat(4)128.72%
EPS beat(8)4
Avg EPS beat(8)16.25%
EPS beat(12)7
Avg EPS beat(12)11.96%
EPS beat(16)10
Avg EPS beat(16)10.9%
Revenue beat(2)0
Avg Revenue beat(2)-2.57%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)-1.89%
Revenue beat(4)0
Avg Revenue beat(4)-4.59%
Min Revenue beat(4)-7.53%
Max Revenue beat(4)-1.89%
Revenue beat(8)0
Avg Revenue beat(8)-4.28%
Revenue beat(12)0
Avg Revenue beat(12)-4.7%
Revenue beat(16)4
Avg Revenue beat(16)-2.38%
PT rev (1m)0%
PT rev (3m)5.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 19.42
Fwd PE 18.73
P/S 1.72
P/FCF 17.42
P/OCF 9.04
P/B 2.12
P/tB 5.89
EV/EBITDA 12.29
EPS(TTM)0.6
EY5.15%
EPS(NY)0.62
Fwd EY5.34%
FCF(TTM)0.67
FCFY5.74%
OCF(TTM)1.29
OCFY11.06%
SpS6.77
BVpS5.5
TBVpS1.98
PEG (NY)5.29
PEG (5Y)N/A
Graham Number8.61
Profitability
Industry RankSector Rank
ROA -6.16%
ROE -17.58%
ROCE 5.51%
ROIC 4.78%
ROICexc 5.04%
ROICexgc 6.77%
OM 11.78%
PM (TTM) N/A
GM 24.21%
FCFM 9.87%
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
ROICexc(3y)6.1%
ROICexc(5y)4.71%
ROICexgc(3y)9.02%
ROICexgc(5y)6.89%
ROCE(3y)6.55%
ROCE(5y)5.06%
ROICexgc growth 3Y19.33%
ROICexgc growth 5Y28.08%
ROICexc growth 3Y19.89%
ROICexc growth 5Y30.34%
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 11.56
Debt/EBITDA 5.01
Cap/Depr 85.17%
Cap/Sales 9.16%
Interest Coverage 1.89
Cash Conversion 84.46%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.07
Altman-Z 1.2
F-Score4
WACC8.42%
ROIC/WACC0.57
Cap/Depr(3y)76.28%
Cap/Depr(5y)73.6%
Cap/Sales(3y)8.81%
Cap/Sales(5y)11.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.45%
EPS 3Y-10.96%
EPS 5Y-12.8%
EPS Q2Q%0%
EPS Next Y3.67%
EPS Next 2Y19.3%
EPS Next 3Y16.08%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.56%
Revenue Next Year10.73%
Revenue Next 2Y9.36%
Revenue Next 3Y10.43%
Revenue Next 5YN/A
EBIT growth 1Y-11.22%
EBIT growth 3Y17.3%
EBIT growth 5Y7.72%
EBIT Next Year33.97%
EBIT Next 3Y16.28%
EBIT Next 5Y13.15%
FCF growth 1Y-4.82%
FCF growth 3Y5.01%
FCF growth 5Y-10.41%
OCF growth 1Y-5.41%
OCF growth 3Y4.89%
OCF growth 5Y-10.96%

ECOVYST INC / ECVT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ECOVYST INC (ECVT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ECVT.


Can you provide the valuation status for ECOVYST INC?

ChartMill assigns a valuation rating of 3 / 10 to ECOVYST INC (ECVT). This can be considered as Overvalued.


What is the profitability of ECVT stock?

ECOVYST INC (ECVT) has a profitability rating of 3 / 10.


What is the financial health of ECOVYST INC (ECVT) stock?

The financial health rating of ECOVYST INC (ECVT) is 4 / 10.


Can you provide the expected EPS growth for ECVT stock?

The Earnings per Share (EPS) of ECOVYST INC (ECVT) is expected to grow by 3.67% in the next year.